TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.46, sa.3, ss.820-824, 2016 (SCI-Expanded)
Background/aim: Systemic isotretinoin treatment is an effective treatment modality for nodulocystic acne, the clinical use of which has been associated with reports of adverse events. We conducted a prospective study with the aim of determining the possible gastrointestinal and laboratory findings of nodulocystic acne patients during systemic isotretinoin treatment.